1-20 of 123
Na Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Variables Associated with Outcomes in Patients with Chronic Neutrophilic Leukemia with CSF3R T618I : A Multi-Centre Retrospective Study

Qian Jiang, Na Xu, Xiaoli Liu, Li Meng, Suning Chen, Jianyong Li, Linhua Yang, Chun-Yan Chen, Limei Chen, Jie Sun, Ling Pan, Minghui Duan, Hongmei Jing, Jinhai Ren, Fengru Lin, Xuemei Qin, Junqing Xu, Robert Peter Gale, Mingfeng Zhao, Zhilan Pan, Xianhua Yuan, Lijuan Cui, Zhijian Xiao, Li Weiming
Journal: Blood
Blood (2024) 144 (Supplement 1): 1793.
https://doi.org/10.1182/blood-2024-207591
Published: 2024
Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan
Journal: Blood
Blood (2024) 144 (Supplement 1): 7385.
https://doi.org/10.1182/blood-2024-203334
Published: 2024
Journal Articles

Intensified Conditioning Containing Decitabine Versus Standard Myeloablative Conditioning for Adult Patients with KMT2A-Rearranged Leukemia: A Multicenter Retrospective Study

Zhongli Hu, Hai He, Shiqi Liu, Ying Dong, Zhiping Fan, Yiqing Li, Fen Huang, Na Xu, Can Liu, Yunxin Zeng, Ping Zhu, Ren Lin, Hua Jin, Xiong Zhang, Ruijuan Sun, Qifa Liu, Li Xuan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2123.
https://doi.org/10.1182/blood-2024-202822
Published: 2024
Journal Articles

Analysis of the Impact of TKI Dose Adjustment Under the Guidance of Blood Concentration Monitoring on the Efficacy, Safety and Quality of Life in Patients with CML

Zherou He, Qing Zhang, Xuan Zhou, Qiang Wang, Xiaoli Liu, Na Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1773.
https://doi.org/10.1182/blood-2024-207302
Published: 2024
Journal Articles

Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Aili He, Qingchi Liu, Xin Du, Sujun Gao, Yarong Li, Yan Li, Yuqing Chen, Wen Wu, Huanling Zhu, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Hongmei Jing, Jishi Wang, Na Xu, Lingling Yue, Cuiping Zheng, ZePing Zhou, Chenghao Jin, Xin Li, Lin Liu, Yajing Xu, Dengshu Wu, Feng Zhang, Jin Zhang, Zhijian Xiao, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3165.
https://doi.org/10.1182/blood-2024-202790
Published: 2024
Journal Articles

The Efficacy and Safety of Selinexor Plus Ruxolitinib Regimen in Ruxolitinib-Resistant Myelofibrosis: A Retrospective Study

Ziyu Wen, Xuan Zhou, Bingyu Lin, Xiaoli Liu, Qiang Wang, Na Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2024-205725
Published: 2024
Journal Articles

Clinical Characteristics and Risk Factors of Chronic Kidney Disease Among Patients with Myeloproliferative Neoplasms

Zicheng Gao, Xuan Zhou, Qiang Wang, Dan Xu, Xiaoli Liu, Na Xu, Qifa Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6643.
https://doi.org/10.1182/blood-2024-207289
Published: 2024
Journal Articles

Safety and Efficacy of Luspatercept for the Treatment of Refractory Anemia in Patients with Myelofibrosis

Ziyu Wen, Xuan Zhou, Bingyu Lin, Xiaoli Liu, Qiang Wang, Na Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6639.
https://doi.org/10.1182/blood-2024-205673
Published: 2024
Journal Articles

Olverembatinib As Second-Line (2L) Therapy in Patients (pts) with Chronic Phase-Chronic Myeloid Leukemia (CP-CML)

Li Weiming, Yanli Zhang, Huanling Zhu, Yunfan Yang, Na Xu, Bingcheng Liu, Zi Chen, Wei Chu, Yifan Zhai, Yu Hu
Journal: Blood
Blood (2024) 144 (Supplement 1): 480.
https://doi.org/10.1182/blood-2024-204996
Published: 2024
Journal Articles

Donor Neutrophil Subsets in G-CSF Mobilized Peripheral Blood Stem Cell to Predict the Risk of Agvhd

Haiyan Zhang, Qiaoyuan Wu, Huajuan Dai, Xinyu Liu, Zhiping Fan, Ren Lin, Na Xu, Qianwei Liu, Qifa Liu, Hua Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4910.
https://doi.org/10.1182/blood-2024-204754
Published: 2024
Journal Articles

Signifcance of Intestinal CD8+CD69+CD103+ Tissue-Resident Memory T Cells in Human Intestinal Acute Graft-Versus-Host Disease

Yiming Sun, Yutong Xue, Ruoyang Shao, Zhiping Fan, Ren Lin, Fen Huang, Na Xu, Hua Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4897.
https://doi.org/10.1182/blood-2024-202219
Published: 2024
Journal Articles

Remarkable Molecular Response in Patients with Polycythemia Vera Treated with Ropeginterferon Alfa-2b

Shanshan Suo, Rongfeng Fu, Albert Qin, Zonghong Shao, Jie Bai, Hu Zhou, Na Xu, Suning Chen, Xuelan Zuo, Xin Du, Minghui Duan, Li Wang, Pei Li, Xuhan Zhang, Sujiang Zhang, Daoxiang WU, Jingjing Zhang, Weihong Shen, Wei Wang, Lei Zhang, Zhijian Xiao, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4562.
https://doi.org/10.1182/blood-2024-203148
Published: 2024
Journal Articles

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4923.
https://doi.org/10.1182/blood-2024-202355
Published: 2024
Journal Articles

Predictive Models for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Fang Cheng, Yu Wang, Xin Du, Yu Zhu, Jianyu Weng, Na Xu, Yunfan Yang, Jian Huang, Zhenfang Liu, Hongbo Ren, Huifang Zhao, Yajuan Ke, Weiyan Wu, Huanling Zhu, Qian Jiang, Yanli Zhang, Weiming Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4540.
https://doi.org/10.1182/blood-2024-202876
Published: 2024
Journal Articles

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Clinical Trials & Observations
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Zhang, Na Xu, Robert Peter Gale, Weiming Li, Xiaoli Liu, Huanling Zhu, Ling Pan, Yunfan Yang, Hai Lin, Xin Du, Rong Liang, Chunyan Chen, Xiaodong Wang, Guohui Li, Zhuogang Liu, Yanqing Zhang, Zhenfang Liu, Jianda Hu, Chunshui Liu, Fei Li, Wei Yang, Li Meng, Yanqiu Han, Li’e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Suning Chen, Huiying Qiu, Lijie Yang, Xiuli Sun, Hui Sun, Li Zhou, Zelin Liu, Danyu Wang, Jianxin Guo, Liping Pang, Qingshu Zeng, Xiaohui Suo, Weihua Zhang, Yuanjun Zheng, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2024) 144 (18): 1951–1961.
https://doi.org/10.1182/blood.2024024761
Published: 2024
Includes: Supplemental data
Journal Articles

Increased Circulating 2-Methylbutyrate Following Fecal Microbiota Transplantation in Patients with Refractory-Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Jing Du, Fen Huang, Kaibo Yang, Na Xu, Zhiping Fan, Li Xuan, Qifa Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 7017.
https://doi.org/10.1182/blood-2023-180818
Published: 2023
Journal Articles

Analysis the Relationship between Clonal Hematopoiesis and Cardiovascular Events in Chronic Myeloid Leukemia Based on Next-Generation Sequencing Technology

Jie Luo, Ziyu Wen, Mengxia Zhao, Zicheng Gao, Hong Chen, Qiang Wang, Xuan Zhou, Zherou He, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Qifa Liu, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1796.
https://doi.org/10.1182/blood-2023-182007
Published: 2023
Journal Articles

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Suning Chen, Yanli Zhang, Na Xu, Hui Sun, Li Weiming, Yunfan Yang, Zunmin Zhu, Minghui Duan, Sixuan Qian, Yu Zhu, Jianmin Luo, Xiaodong Wang, Wei Yang, Weiying Gu, Fei Li, Bingcheng Liu, Yunxiao Xu, Zhenfang Liu, Chunling Wang, Yirong Jiang, Li Meng, Qin Wen, Yanli Xu, Xingli Zou, Wei Wang, Yan Xue, Hao Xu, Kehong Bi, Fuling Zhou, Liangming Ma, Rong Fu, Guifang Ouyang, Kaiyang Ding, Depei Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1797.
https://doi.org/10.1182/blood-2023-179073
Published: 2023
Journal Articles

Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and Dasatinib

Li Weiming, Yanli Zhang, Zhiwei Wu, Qin Wen, Qing Leng, Shuting Wu, Xiaodong Wang, Shiming Chen, Guolin Yuan, Sixuan Qian, Suning Chen, Daozi Jiang, Lianjun Diao, Zhenfang Xi, Hui Wu, Hui Sun, Lijie Yang, Hongjuan Wang, Xuefang Zhang, Yanli Xu, Xielan Zhao, Na Xu, Li Meng, Zunmin Zhu, Youfang Zhao, Meifang Su, Zhuangzhi Yang, Chuancai Liu, Danlei Han, Yu Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3171.
https://doi.org/10.1182/blood-2023-179142
Published: 2023
Journal Articles

Disruption of SOCS1 Promotes the Antitumor Activity of CD19-Specific CAR NK Cells Coexpressing IL-15

Hong Chen, Bailin He, Suzhen Zhong, Dongchao Huang, Shikai Deng, Qifa Liu, Chengyao Li, Lizhen Huang, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6829.
https://doi.org/10.1182/blood-2023-182516
Published: 2023